Published in Cerebrovasc Dis on December 22, 2010
Increased arterial diameters in the posterior cerebral circulation in men with Fabry disease. PLoS One (2014) 0.82
Stroke and Fabry disease. J Neurol (2011) 0.80
Fabry disease - underestimated in the differential diagnosis of multiple sclerosis? PLoS One (2013) 0.80
Fabry disease: multidisciplinary evaluation after 10 years of treatment with agalsidase Beta. JIMD Rep (2014) 0.77
Eight-Year Follow-Up of Neuropsychiatric Symptoms and Brain Structural Changes in Fabry Disease. PLoS One (2015) 0.75
A comparison of central nervous system involvement in patients with classical Fabry disease or the later-onset subtype with the IVS4+919G>A mutation. BMC Neurol (2017) 0.75
Biomarkers and Imaging Findings of Anderson-Fabry Disease-What We Know Now. Diseases (2017) 0.75
Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med (2004) 25.68
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol (2005) 6.00
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol (2012) 5.91
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol (2010) 3.88
Addition of milk prevents vascular protective effects of tea. Eur Heart J (2007) 2.80
Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin. Gastroenterology (2006) 2.62
Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial. Lancet Neurol (2012) 2.59
Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet (2005) 2.59
Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke (2005) 2.59
Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke (2008) 2.57
MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol (2006) 2.44
Impact of sleep deprivation on medium-term psychomotor and cognitive performance of surgeons: prospective cross-over study with a virtual surgery simulator and psychometric tests. Surgery (2010) 2.39
Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med (2012) 2.38
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37
White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol (2005) 2.29
Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94. Int J Radiat Oncol Biol Phys (2006) 2.26
The impact of aging and gender on brain viscoelasticity. Neuroimage (2009) 2.15
Diffusion tensor imaging using single-shot SENSE-EPI. Magn Reson Med (2002) 2.14
Expert opinion on temporary treatment recommendations for Fabry disease during the shortage of enzyme replacement therapy (ERT). Mol Genet Metab (2010) 2.13
Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg (2009) 2.06
High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol (2009) 1.98
Acute unilateral hearing loss as an early symptom of lateral cerebral sinus venous thrombosis. Arch Neurol (2012) 1.97
Impact of age-related cerebral white matter changes on the transition to disability -- the LADIS study: rationale, design and methodology. Neuroepidemiology (2005) 1.92
Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke (2006) 1.88
Quantitative MR imaging of brain iron: a postmortem validation study. Radiology (2010) 1.86
MR-elastography reveals degradation of tissue integrity in multiple sclerosis. Neuroimage (2009) 1.83
A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med (2003) 1.83
Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet (2012) 1.79
On the etiology of incident brain lacunes: longitudinal observations from the LADIS study. Stroke (2008) 1.75
Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage (2012) 1.74
Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol (2012) 1.70
Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet (2003) 1.70
Surgery for primary CNS lymphoma? Challenging a paradigm. Neuro Oncol (2012) 1.68
Computed tomography angiography and myocardial computed tomography perfusion in patients with coronary stents: prospective intraindividual comparison with conventional coronary angiography. J Am Coll Cardiol (2013) 1.67
Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema. Arch Ophthalmol (2005) 1.66
Point-of-care laboratory halves door-to-therapy-decision time in acute stroke. Ann Neurol (2011) 1.59
Bringing the hospital to the patient: first treatment of stroke patients at the emergency site. PLoS One (2010) 1.59
International study on low-grade primary central nervous system lymphoma. Ann Neurol (2006) 1.59
Tuberculin-specific T cells are reduced in active pulmonary tuberculosis compared to LTBI or status post BCG vaccination. J Infect Dis (2010) 1.58
High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults. J Clin Oncol (2006) 1.57
Diagnostic difficulties in Krabbe disease: a report of two cases and review of literature. Folia Neuropathol (2012) 1.55
CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory. Med Pediatr Oncol (2002) 1.55
Diffusion changes predict cognitive and functional outcome: the LADIS study. Ann Neurol (2013) 1.54
Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. Am J Psychiatry (2008) 1.53
Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med (2007) 1.52
Common variants at 6q22 and 17q21 are associated with intracranial volume. Nat Genet (2012) 1.51
Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study. Eur J Endocrinol (2010) 1.48
Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute. Strahlenther Onkol (2004) 1.48
Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele. Arch Neurol (2003) 1.48
Small neuroretinal rim and large parapapillary atrophy as predictive factors for progression of glaucomatous optic neuropathy. Ophthalmology (2002) 1.47
Heterogeneity in age-related white matter changes. Acta Neuropathol (2011) 1.47
Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium. Stroke (2009) 1.47
Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders. Neurology (2014) 1.45
An impaired neocortical Ih is associated with enhanced excitability and absence epilepsy. Eur J Neurosci (2004) 1.43
Prevalence of stenoses and occlusions of brain-supplying arteries in young stroke patients. Neurology (2013) 1.42
Surgery-related factors influencing corneal neovascularization after low-risk keratoplasty. Am J Ophthalmol (2006) 1.41
Differences in cerebral activation patterns in idiopathic inflammatory demyelination using the paced visual serial addition task: an fMRI study. J Neurol Sci (2006) 1.40
2001-2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease? Cerebrovasc Dis (2011) 1.40
Visualization of hypervascular liver lesions During TACE: comparison of angiographic C-arm CT and MDCT. AJR Am J Roentgenol (2008) 1.37
Progression of leukoaraiosis and cognition. Stroke (2007) 1.36
Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study. Graefes Arch Clin Exp Ophthalmol (2002) 1.33
Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload. Am J Physiol Regul Integr Comp Physiol (2010) 1.32
Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome. J Clin Oncol (2007) 1.32
Transient global amnesia: diffusion-weighted imaging lesions and cerebrovascular disease. Stroke (2008) 1.32
Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas. Haematologica (2012) 1.30
Brain activity changes associated with treadmill training after stroke. Stroke (2009) 1.29
Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors. J Neurooncol (2006) 1.26
Susceptibility induced gray-white matter MRI contrast in the human brain. Neuroimage (2011) 1.26
Method for quantitative imaging of the macromolecular 1H fraction in tissues. Magn Reson Med (2003) 1.26
Brain atrophy and lesion load predict long term disability in multiple sclerosis. J Neurol Neurosurg Psychiatry (2013) 1.26
Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients study. Stroke (2013) 1.25
Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study. Cerebrovasc Dis (2009) 1.25
Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease. Brain (2013) 1.25
Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone. Antimicrob Agents Chemother (2003) 1.25
Quantitative susceptibility mapping in multiple sclerosis. Radiology (2013) 1.23
Enamel and dentine remineralization by nano-hydroxyapatite toothpastes. J Dent (2011) 1.20
Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovasc Dis (2006) 1.20
Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan. Hum Brain Mapp (2013) 1.20
MTI of white matter hyperintensities. Brain (2005) 1.19
High prevalence of Giardia duodenalis Assemblage B infection and association with underweight in Rwandan children. PLoS Negl Trop Dis (2012) 1.19
Functional relevant loss of long association fibre tracts integrity in early Alzheimer's disease. Neuropsychologia (2007) 1.18
Estrogen receptor alpha up-regulation and redistribution in human heart failure. FASEB J (2006) 1.18